FDA delays decision on key Alexion drug by 3 months
September 04, 2015 at 08:49 AM EDT
Sept 4 (Reuters) - Alexion Pharmaceuticals Inc said the U.S. Food and Drug Administration would delay by three months its decision on approving a key drug the company got through the acquisition of Synageva BioPharma Corp.